TotalMarketCap

Inventiva

IVANasdaq FranceHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$857.697 M

$3.63 -6.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Inventiva (IVA) has a market capitalization of $857.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

193,236,978

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #151Latigo BiotherapeuticsLTGO$865.9M
  2. #152Alto NeuroscienceANRO$861.0M
  3. #153InventivaIVA$857.7M
  4. #154City TherapeuticsCTY$855.1M
  5. #155Rigel PharmaceuticalsRIGL$848.1M

What if Inventiva were worth as much as…

Open the what-if tool →

Gold $28.2T

$119,505.88

Per share 32,922× higher

Bitcoin $1.53T

$6,466.26

Per share 1,781× higher

Apple $5.02T

$21,228.11

Per share 5,848× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Inventiva are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.